Cargando…
Aseptic Meningitis after Amenamevir Treatment for Herpes Zoster in the First Branch of the Trigeminal Nerve
Amenamevir has been approved for the treatment of herpes zoster (HZ); however, its therapeutic efficacy against central nervous system (CNS) infection may be insufficient due to its low spinal fluid permeability. We herein report a case of aseptic meningitis in a 91-year-old Japanese man treated wit...
Autores principales: | Itoh, Kazuhiro, Mitsuke, Yasuhiko, Wakahara, Mami, Yoshioka, Tatsuya, Otsuki, Nozomi, Suzuki, Yusuke, Kiriba, Chiyo, Kuwata, Atsushi, Sakamaki, Ippei, Iwasaki, Hiromichi, Tsutani, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556230/ https://www.ncbi.nlm.nih.gov/pubmed/35228415 http://dx.doi.org/10.2169/internalmedicine.8581-21 |
Ejemplares similares
-
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2021) -
The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021) -
Potential Use of Iron-Limiting Therapy against Cryptococcus neoformans and Effects of Caspofungin on the Host Immune System
por: Itoh, Kazuhiro, et al.
Publicado: (2022) -
Two possible mechanisms of ganciclovir for treatment of major depressive disorder
por: Itoh, Kazuhiro, et al.
Publicado: (2023) -
Potential additional effects of iron chelators on antimicrobial- impregnated central venous catheters
por: Itoh, Kazuhiro, et al.
Publicado: (2023)